Literature DB >> 20590851

Biovigilance and pharmacovigilance for haemophilia.

M Weinstein1, M Makris, C A Ludlam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20590851     DOI： 10.1111/j.1365-2516.2010.02288.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

Review 1.  The European Haemophilia Network (EUHANET).

Authors:  Michael Makris; Gabriele Calizzani; Kathelijn Fischer; Alexander Gatt; Estelle Gilman; Robert Hollingsworth; Thierry Lambert; Riitta Lassila; Pier Mannuccio Mannucci; Flora Peyvandi; Jerzy Windyga
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

Review 2.  Biovigilance: A Global Perspective.

Authors:  Sukhjinder Singh; Shammy Chandel; Phulen Sarma; Dibbanti Harikrishna Reddy; Abhishek Mishra; Subodh Kumar; Prasad Thota; Kotni Murali; Ajay Prakash; Bikash Medhi
Journal:  Perspect Clin Res       Date:  2019 Oct-Dec

3.  Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol.

Authors:  Ricardo Mesquita Camelo; Daniel Gonçalves Chaves; Luciana Werneck Zuccherato; Suely Meireles Rezende
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.